{
    "Trade/Device Name(s)": [
        "AVantage\u2122 A/H5N1 Flu Test"
    ],
    "Submitter Information": "Arbor Vita Corporation",
    "510(k) Number": "K083278",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080570",
        "K053146"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OMS"
    ],
    "Summary Letter Date": "April 7, 2009",
    "Summary Letter Received Date": "April 7, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3332"
    ],
    "Regulation Name(s)": [
        "Reagent for detection of specific novel influenza A viruses"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A/H5N1 NS1 antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Throat swab",
        "Viral culture"
    ],
    "Specimen Container(s)": [
        "M4 viral transport media",
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Monoclonal antibody detection",
        "Recombinant protein capture"
    ],
    "Methodologies": [
        "Visual detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Cassette",
        "Reagent",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for AVantage\u2122 A/H5N1 Flu Test, a rapid immunochromatographic assay for qualitative detection of influenza A/H5N1 NS1 antigen in nasal or throat swabs and viral cultures.",
    "Indications for Use Summary": "Intended for the in vitro qualitative detection of influenza A/H5N1 virus directly from symptomatic patient nasal or throat swab specimens or viral cultures for presumptive laboratory identification; prescription use in conjunction with other lab and clinical information.",
    "fda_folder": "Microbiology"
}